The AAV CDMO market is booming, projected to reach $0.57B in 2025 with a 20.86% CAGR. Driven by cell & gene therapy, vaccine, and biopharmaceutical demands, this report analyzes market segments, key players (like Thermo Fisher & Charles River), regional trends (North America leading, Asia-Pacific rapidly growing), and future growth projections through 2033.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.